Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...

Vivos Therapeutics shares dropped Thursday after the company said it is offering 1.4 million common shares at $3.15 per share in a registered direct offering. Shares were down 27% to $3.03 in recent ...

Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering ...

The House passed 14 bipartisan health bills. Here's a rundown on the legislation from the office of Rep. Cathy McMorris ...

Vivos Therapeutics, Inc. (VVOS), a medical device and technology company, announced on Thursday that it has inked a deal with ...

LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) --. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization ...

Vivos Therapeutics shares surged 47.50% to close at $4.13, after hitting an intraday high of $5.95 and a low of $3.02. The ...

On Wednesday, Vivos Therapeutics Inc (VVOS) stock saw a modest uptick, ending the day at $4.13 which represents a slight increase of $1.33 or 47.50% from the prior close of $2.8. The stock opened at ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

Charting, Price Performance, News & Related Contracts.